Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11530, first published .
Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Fabienne Lecomte   1 , MSc ;   Anne Sophie Vignion-Dewalle   1 , PhD ;   Claire Vicentini   1, 2 , MD ;   Elise Thecua   1 , MSc ;   Pascal Deleporte   1 , BSc ;   Alain Duhamel   3 , PhD ;   Serge Mordon   1 , PhD ;   Laurent Mortier   1, 2 , MD, PhD

1 U1189 - Image Assisted Laser Therapies for Oncology, Inserm, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille, France

2 Department of Dermatology, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille, France

3 EA 2694 - Santé Publique: Epidémiologie et Qualité des Soins, Unité de Biostatistiques, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille, France

Corresponding Author:

  • Fabienne Lecomte, MSc
  • U1189 - Image Assisted Laser Therapies for Oncology, Inserm
  • Centre Hospitalier et Universitaire de Lille
  • Université de Lille
  • 1 avenue Oscar Lambret
  • Lille, 59037
  • France
  • Phone: 33 3 20 44 67 22
  • Email: fabienne.lecomte@inserm.fr